Semax

What is the Semax Peptide?

The Semax peptide is an advanced neuroactive heptapeptide developed to replicate and extend the physiological mechanisms of the natural melanocortin system. By bonding the core ACTH fragment with a stabilizing Pro-Gly-Pro tripeptide sequence at its C-terminus, the molecule gains profound protection against rapid enzymatic degradation, allowing for enhanced half-life and stability in organic environments.

The primary mechanism of action of the Semax peptide relies on its unique capacity to trigger a rapid upregulation of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) within the hippocampus and frontal cortex. Unlike traditional central nervous system stimulants, it operates without causing locomotor agitation or downstream receptor depletion, functioning instead as a selective modifier of cellular survival, synaptic plasticity, and neurotransmitter balance.

Key Scientific Applications & Research Benefits

In laboratory models, neuro-degenerative frameworks, and cognitive performance studies, the Semax peptide is extensively evaluated for its distinct biochemical mechanisms:

1. Upregulation of Neurotrophins and Neuroplasticity

Research indicates that the Semax peptide rapidly elevates mRNA expression for both BDNF and NGF following introduction. This shift encourages the proliferation of neural progenitor cells, accelerates synaptic remodeling, and supports long-term potentiation (LTP) baselines critical for studying memory consolidation and accelerated learning dynamics.

2. Neuroprotective Signaling Against Ischemic Trauma

In stroke and hypoxia evaluation models, Semax is heavily utilized to study its potent cytoprotective profile. Scientific literature highlights its ability to modulate localized inflammatory responses, decrease nitric oxide-driven toxicity, and support cell survival metrics within vulnerable brain tissues under physical or metabolic stress.

3. Modulation of Monoaminergic and Dopaminergic Pathways

Semax exerts a balancing influence on systemic monoamine neurotransmitters. By regulating the active turnover of dopamine and serotonin, it assists researchers in mapping pathways related to sustained attention spans, mental clarity, and exploratory behavior profiles during demanding environmental simulations.

4. Attenuation of Optic Nerve Pathology and Retinal Health

Emerging research points toward Semax providing significant trophic support to ocular neural systems. It is actively evaluated in glaucoma and optic nerve degradation models to analyze how targeting melanocortin pathways can preserve visual signaling architecture and reduce structural cellular decay.

Technical Specifications & Laboratory Guidelines

Every 10mg vial is manufactured under strict quality assurance parameters to protect your experimental integrity and guarantee precise reproducibility:

• CAS Number: 80714-61-0
• Molecular Formula: C39H57N11O9S
• Molecular Mass: 857.99 g/mol
• Purity Profile: ≥98% via High-Performance Liquid Chromatography (HPLC)
• Storage Conditions: Lyophilized powder remains structurally stable at room temperature for up to 90 days. For long-term preservation, store at -20°C. Following reconstitution with sterile BAC water, store tightly refrigerated at 2°C–8°C and utilize within 30 days to protect against active compound degradation.

Disclaimer: This product is synthesized, manufactured, and distributed strictly for laboratory research, in vitro diagnostic evaluation, and scientific analysis. It is not approved or intended for direct human therapeutic use, cosmetic applications, or consumer ingestion.